Demant Financials

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>DA</div>
Understanding current and past Demant AS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We urge to utilize Demant AS fundamental analysis to find out if markets are presently mispricing the company. Put another way you can exercise it to find out if Demant AS is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found twenty-six available fundamental indicators for Demant AS, which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Demant AS financials, including its Price to Sales, Debt to Equity, Z Score, as well as the relationship between Net Income and Earnings Per Share .

Search Fundamentals

With this module, you can analyze Demant financials for your investing period. You should be able to track the changes in Demant AS individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Chance of Financial Distress

Demant AS has less than 41 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of ods of distress for Demant AS stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info

Demant AS Company Summary

Demant AS, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant AS operates under Medical Instruments Supplies classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 14614 people.
InstrumentDenmark Stock View All
ExchangeCopenhagen Stock Exchange
Business AddressKongebakken 9
IndustryMedical Instruments & Supplies
Phone45 39 17 73 00
CurrencyDKK - Danish Krone

Demant AS Key Financial Ratios

Demant Financial Ratios Relationships

Demant AS is one of the top stocks in return on asset category among related companies. It is one of the top stocks in operating margin category among related companies reporting about  1.96  of Operating Margin per Return On Asset.

Demant AS Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Investing Opportunities. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page